COVID-19 has affected many countries in Europe in beyond. There is currently a growing interest to quantify the disease burden of COVID-19, in order to measure its population health impact and compare it to other diseases. On this page, we compile burden of disease resources specifically focused on COVID-19.
Burden of COVID-19 Working Group
The Burden of COVID-19 Working Group brings together members who are conducting or interested in launching national studies to estimate the burden of disease of COVID-19. The WG meets approximately every six weeks to discuss technical aspects of COVID-19 burden calculation.
More information about the Working Group is available here.
Burden of COVID-19 calculation protocol
The burden-eu Core Group has prepared a protocol to provide guidance for anyone planning to assess the burden of disease of COVID-19 at national level using DALYs. It focuses on the direct health impact of the disease, and describes the data requirements, the methods, and considerations for communicating results. It also aims to foster harmonization of methodologies for estimating the burden of disease of COVID-19 across countries.
You can download the protocol here.
Burden of COVID-19 webinars
On Friday 20 November 2020, our COST Action has organized a webinar on quantifying COVID-19 disease burden. You can replay the webinar and access the presentations here.
Burden of COVID-19 publications
DALY calculation methods for COVID-19
Wyper GM, Assunção RM, Colzani E, Grant I, Haagsma JA, Lagerweij G, Von der Lippe E, McDonald SA, Pires SM, Porst M, Speybroeck N, Devleesschauwer B. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. Int J Public Health. 2021;66:619011. doi: 10.3389/ijph.2021.619011
Devleesschauwer B, McDonald SA, Speybroeck N, Wyper GM. Valuing the years of life lost due to COVID-19: the differences and pitfalls. Int J Public Health. 2020;65:719–720. doi: 10.1007/s00038-020-01430-2
DALY calculations for COVID-19 — peer-reviewed
Fan CY, Fann JC, Yang MC, Lin TY, Chen HH, Liu JT, Yang KC. Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics. J Formos Med Assoc. 2021:S0929-6646(21)00234-5. doi: 10.1016/j.jfma.2021.05.019
He M, Li X, Tan Q, Chen Y, Kong Y, You J, Lin X, Lin Y, Zheng Q. Disease burden from COVID-19 symptoms among inpatients at the temporary military hospitals in Wuhan: a retrospective multicentre cross–sectional study. BMJ Open. 2021;11(5):e048822. doi: 10.1136/bmjopen-2021-048822
Quast T, Andel R, Gregory S, Storch EA. Years of life lost associated with COVID-19 deaths in the USA during the first year of the pandemic. J Public Health. 2021; in press. doi: 10.1093/pubmed/fdab123
Vasishtha G, Mohanty SK, Mishra US, Dubey M, Sahoo U. Impact of COVID-19 infection on life expectancy, premature mortality, and DALY in Maharashtra, India. BMC Infect Dis. 2021;21:343. doi: 10.1186/s12879-021-06026-6
Lagerweij G, Schimmer B, Mooij S, Raven S, Schoffelen A, de Gier B, Hahné D. State of Infectious Diseases in the Netherlands, 2019. RIVM-Rapport 2020-0048. doi: 10.21945/rivm-2020-0048
Rommel A, von der Lippe E, Plass D, Ziese T, Diercke M, An der Heiden M, Haller S, Wengler A. The COVID-19 disease burden in Germany in 2020—years of life lost to death and disease over the course of the pandemic. Dtsch Arztebl Int. 2021;118:arztebl.m2021.0147. doi: 10.3238/arztebl.m2021.0147
Zhao J, Jin H, Li X, Jia J, Zhang C, Zhao H, Ma W, Wang Z, He Y, Lee J, Zhang D, Yin B, Zheng W, Wang H, Pennington M. Disease burden attributable to the first wave of COVID-19 in China and the effect of timing on the cost-effectiveness of movement restriction policies. Value Health. 2021; in press. doi: 10.1016/j.jval.2020.12.009
Pifarré i Arolas H, Acosta E, López-Casasnovas G, Lo A, Nicodemo C, Riffe T, Myrskylä M. Years of life lost to COVID-19 in 81 countries. Sci Rep. 2021;11:3504. doi: 10.1038/s41598-021-83040-3
Ortiz-Prado E, Simbaña-Rivera K, Barreno LG, Diaz AM, Barreto A, Moyano C, Arcos V, Vásconez-González E, Paz C, Simbaña-Guaycha F, Molestina-Luzuriaga M, Fernández-Naranjo R, Feijoo J, Henriquez AR, Adana L, Cortés AL, Fletcher I, Lowe R. Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador. PLOS Negl Trop Dis. 2020;15(1):e0008958. doi: 10.1371/journal.pntd.0008958
Mitra AK, Payton M, Kabir N, Whitehead A, Ragland KN, Brown A. Potential Years of Life Lost due to COVID-19 in the United States, Italy, and Germany: an old formula with newer ideas. Int J Environ Res Public Health. 2020;17(12):4392. doi: 10.3390/ijerph17124392
Oh IH, Ock M, Jang SY, Go DS, Kim YE, Jung YS, Kim KB, Park H, Jo MW, Yoon SJ. Years of Life Lost attributable to COVID-19 in high-incidence countries. J Korean Med Sci. 2020;35(32):e300. doi: 10.3346/jkms.2020.35.e300
Bell D, Schultz Hansen K, Kiragga AN, Kambugu A, Kissa J, Mbonye AK. Predicting the impact of COVID-19 and the potential impact of the public health response on disease burden in Uganda. Am J Trop Med Hyg. 2020; in press. doi: 10.4269/ajtmh.20-0546
Tchole AIM, Li ZW, Wei JT, Ye RZ, Wang WJ, Du WY, Wang HT, Yin CN, Ji XK, Xue FZ, Bachir AM, Zhao L, Cao WC, Cheeloo EcoHealth Consortium (CLEC). Epidemic and control of COVID-19 in Niger: quantitative analyses in a least developed country. J Glob Health. 2020;10(2):020513. doi: 10.7189/jogh.10.020513
Nurchis MC, Pascucci D, Sapienza M, Villani L, D’Ambrosio F, Castrini F, Specchia ML, Laurenti P, Damiani G. Impact of the burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17:4233. doi: 10.3390/ijerph17124233
Jo MW, Go DS, Kim R, Lee SW, Ock M, Kim YE, Oh IH, Yoon SJ, Park H. The burden of disease due to COVID-19 in Korea using Disability-Adjusted Life Years. J Korean Med Sci. 2020;35(21):e199. doi: 10.3346/jkms.2020.35.e199
DALY calculations for COVID-19 — non peer-reviewed
Wyper GMA, Fletcher E, Grant I, Harding O, de Haro Moro MT, Stockton DL, McCartney G. Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland. SocArXiv. June 15, 2021. doi: 10.31235/osf.io/js3h6
Cuschieri S, Calleja N, Devleesschauwer B, Wyper GMA. Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year. SocArXiv. June 10, 2021. doi: 10.31235/osf.io/8gdrs
Bell D, Hansen KS. Relative burdens of the COVID-19, malaria, tuberculosis and HIV/AIDS epidemics in sub-Saharan Africa in 2020. medRxiv. March 29, 2021. doi: 10.1101/2021.03.27.21254483
Wyper GMA, Fletcher E, Grant I, McCartney G, Fischbacher C, Harding O, Jones H, de Haro Moro MT, Speybroeck N, Devleesschauwer B, Stockton DL. Measuring the direct population impact of COVID-19 in Scotland, 2020: estimating disability-adjusted life years (DALYs) during the first full calendar year. SocArXiv. March 24, 2021. doi: 10.31235/osf.io/ey36d
John D, Narassima MS, Menon JC, GR Jammy GR. Estimation of economic burden of COVID-19 using Disability-Adjusted Life Years (DALYs) and Productivity Losses in Kerala state, India. Research Square. December 2, 2020. doi: 10.21203/rs.3.rs-118146/v2
Mirzaee N, Barouni M, Goudarzi R, Jahani Y, Haghdoost AA, Gohari MA, Nakhaeizadeh M, McFarland W, Sharifi H. Prediction the burden of COVID-19 in Iran: Application of disability-adjusted life years (DALYs). Research Square. September 21, 2020. doi: 10.21203/rs.3.rs-78334/v1
Mohanty SK, Dubey M, Mishra US, Sahoo U. Impact of COVID-19 attributable deaths on longevity, premature mortality and DALY: Estimates of USA, Italy, Sweden and Germany. medRxiv. July 07, 2020. doi: 10.1101/2020.07.06.20147009
Mohanty SK, Sahoo U, Mishra US, Dubey M. Age pattern of premature mortality under varying scenarios of COVID-19 infection in India. medRxiv. June 12, 2020. doi: 10.1101/2020.06.11.20128587
Khan S. Can we estimate the Disability Adjusted Life-Years (DALYs) for COVID-19 yet? https://covid19waterblog.wordpress.com/2020/05/28/can-we-estimate-the-disability-adjusted-life-years-dalys-for-covid-19-yet/
COVID-19 and burden of disease context
Noy I, Doan N, Ferrarini B, Park D. Measuring the economic risk of COVID‐19. Global Policy. 2020;11(4):413-23. doi: 10.1111/1758-5899.12851
Azarpazhooh MR, Morovatdar N, Avan A, Phan TG, Divani AA, Yassi N, Stranges S, Silver B, Biller J, Tokazebani Belasi M, Kazemi Neya S, Khorram B, Frydman A, Nilanont Y, Onorati E, Di Napoli M. COVID-19 pandemic and burden of non-communicable diseases: an ecological study on data of 185 countries. J Stroke Cerebrovasc Dis. 2020;29(9):105089. doi: 10.1016/j.jstrokecerebrovasdis.2020.105089
Wyper GM, Assunção RM, Cuschieri S, Devleeschauwer B, Fletcher E, Haagsma JA, Hilderink H, Idavain J, Lesnik T, Von der Lippe E, Majdan M, Santric-Milicevic M, Pallari E, Peñalvo JL, Pires SM, Plass D, Santos JV, Stockton DL, Thomsen ST, Grant I. Population vulnerability to COVID-19 in Europe: a burden of disease analysis. Arch Public Health. 2020;78:47. doi: 10.1186/s13690-020-00433-y